Stock Report

Download full stock data and analysis for free Last Updated: 25-Oct-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Apellis Pharmaceuticals (APLS) Peer Comparison

Stock Card factsheet share-fund-plan-icon

$41.03

$0.00 (0.00%)

As on 15-May-2026 16:00EDT

Market cap

info icon

$5,253 Mln

Revenue (TTM)

info icon

$1,105 Mln

P/E Ratio

info icon

38.3

P/B Ratio

info icon

12.7

Div. Yield

info icon

0 %

Edit peer-selector-edit
Apellis Pharmaceuticals (APLS) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Dr. Reddy's Laboratories - ADR
Market cap ($ Mln)
 5,253 12,979 11,908 11,248 11,022
Revenue ($ Mln)
 1,105 713 831 5,020 332,834
Net Profit ($ Mln)
 133.27 -696.24 54.90 -199.00 33,166.55
Net Margin (%)
 12.06 -97.64 6.61 -3.96 9.96
RoE (%)
 32.66 -- 8.11 -3.03 8.88
Price to Earnings
 38.35 -- 244.80 -- 30.07
Price-To-Book
 12.66 123.68 18.00 1.73 2.58

Income Statement ($ Mln)

Apellis Pharmaceuticals (APLS) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Dr. Reddy's Laboratories - ADR
Operating Revenue arrow
1,105.28 713.07 830.81 5,020.00 332,834.17
Cost of Revenue arrow
109.16 47.45 14.09 2,380.00 165,910.29
Gross Profit arrow
901.55 473.81 748.43 2,050.00 190,428.00
Operating Expenses arrow
831.19 1,209.09 810.32 2,178.00 131,728.10
Operating Profit (EBIT) arrow
165.22 -543.47 6.41 462.00 35,195.77
Other Income arrow
0.00 0.00 0.00 0.00 0.00
Profit before Tax arrow
135.15 -706.17 26.37 -166.00 41,359.76
Provision for Tax arrow
1.88 -7.73 -35.26 33.00 8,582.66
Profit after Tax (Net Income) arrow
133.27 -696.24 54.90 -199.00 33,166.55
Minority Interest arrow
0.00 10.15 0.00 0.00 389.00
Consolidated Profit arrow
0.00 0.00 0.00 0.00 25,570.00

Liabilities ($ Mln)

Apellis Pharmaceuticals (APLS) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Dr. Reddy's Laboratories - ADR
Shareholder's Funds arrow
414.92 -2,515.22 705.78 6,588.00 383,428.00
Minority Interest arrow
0.00 10.15 0.00 0.00 389.00
Non-Current Liabilities arrow
384.16 2,832.54 29.12 5,121.00 31,229.00
Current Liabilities arrow
283.45 890.65 153.80 1,852.00 157,341.00
Total Liabilities arrow
1,075.26 936.03 836.65 13,358.00 492,989.00

Assets ($ Mln)

Apellis Pharmaceuticals (APLS) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Dr. Reddy's Laboratories - ADR
Non-Current Assets arrow
54.51 124.16 449.03 9,764.00 275,974.00
Current Assets arrow
1,028.02 1,093.14 439.68 3,797.00 299,331.00
Total Assets arrow
1,075.26 936.03 836.65 13,358.00 492,989.00
Total Debt* arrow
475.76 2,493.78 9.42 3,918.00 71,952.00
Net Current Assets arrow
744.57 202.49 285.87 1,945.00 141,990.00

Cashflow ($ Mln)

Apellis Pharmaceuticals (APLS) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Dr. Reddy's Laboratories - ADR
Cash From Operating Activities arrow
45.33 -445.91 142.00 560.00 46,428.00
Cash Flow from Investing Activities arrow
-0.31 -24.49 69.76 -279.00 -58,077.00
Cash from Financing Activities arrow
8.88 359.29 -220.37 -275.00 18,911.00
Net Cash Inflow / Outflow arrow
-- -- -- -- --

Ratios

Profitability Ratios

 Apellis Pharmaceuticals (APLS) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Dr. Reddy's Laboratories - ADR
ROCE (%) arrow
2.88 -159.44 14.87 -2.21 16.61
ROE (%) arrow
32.66 41.15 8.11 -3.03 8.88
ROA (%) arrow
11.33 -41.39 5.52 -1.30 4.76
EBIT Margin (%) arrow
16.17 -86.43 3.17 1.61 11.97
Net Margin (%) arrow
12.06 -97.64 6.61 -3.96 9.96
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Apellis Pharmaceuticals (APLS) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Dr. Reddy's Laboratories - ADR
Revenue Growth (%) arrow
42.46 202.39 16.02 11.95 -0.43
EBIT Growth (%) arrow
200.49 5.05 -79.11 -90.61 -50.25
Net Profit Growth (%) arrow
159.58 10.33 -58.66 -145.85 -41.61
EPS Growth (%) arrow
158.88 12.58 -62.44 -146.42 -41.56
Book Value Growth (%) arrow
151.52 -36.90 12.98 -3.87 9.58

Valuation Ratios

 Apellis Pharmaceuticals (APLS) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Dr. Reddy's Laboratories - ADR
Price / Earnings arrow
141.40 -20.69 41.86 -48.47 0.19
Price / Book Value arrow
8.55 -7.27 6.44 1.73 2.58
Dividend Yield (%) arrow
-- -- -- 0.00 0.63
EV/EBITDA arrow
45.49 -25.47 55.67 19.02 0.01
Market Cap ($ Cr) arrow
-- -- -- -- --

Solvency Ratios

 Apellis Pharmaceuticals (APLS) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Dr. Reddy's Laboratories - ADR
Debt to Equity arrow
0.87 -0.77 0.00 0.58 0.00
Short term debt to equity ratio arrow
0.24 -0.22 0.00 0.01 0.16
Current Ratio arrow
3.63 1.23 2.86 2.05 1.90
Quick Ratio arrow
3.16 1.17 2.77 1.10 1.39
Interest Coverage arrow
4.10 -6.86 -- 0.36 10.86

Operating Efficiency Ratios

 Apellis Pharmaceuticals (APLS) BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Dr. Reddy's Laboratories - ADR
Debtors to sales (%) arrow
40.27 35.69 9.26 22.95 37.38
Asset Turnover arrow
0.94 0.42 0.84 0.33 0.48
Receivable days arrow
116.07 52.44 28.27 70.73 115.08
Inventory Days arrow
401.99 172.81 355.76 226.89 181.99
Payable days arrow
170.36 296.14 785.55 45.50 56.23
Cash Conversion Cycle arrow
347.70 -70.89 -401.52 252.12 240.84
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...